Literature DB >> 23850181

Rapidly progressing fatal reperfusion syndrome caused by acute critical ischemia of the lower limb.

Attila Szijártó1, Zsolt Turóczi, József Szabó, Péter Kaliszky, Endre Gyurkovics, Péter Arányi, László Regáli, László Harsányi, Gábor Lotz.   

Abstract

The most severe complication of ischemia-reperfusion injury following lower limb arterial surgery is reperfusion syndrome. Therefore, our aim was to describe the extent of muscle damage and the reperfusion syndrome-related remote organ lesions in detail, through a well-documented case of long-lasting infrarenal aorta thrombosis. After urgent revascularization, several clinical signs of multiple organ dysfunction were detectable, including the circulatory, urinary, respiratory, gastrointestinal, and hemostatic systems. Upon histological examination, intraoperative muscle biopsy showed severe muscle damage. Muscle fiber viability was assessed with a special nitroblue tetrazolium staining-based viability test developed by our team; the obtained results indicated significant degree of muscle damage before this was confirmed by conventional histological methods. Thorough postmortem examination confirmed the presence of remote organ damage. The pathological findings included acute tubular necrosis, myocardial and jejunal infarctions, ischemic pancreatitis, and diffuse alveolar damage with hyaline membrane formation in the lungs and focal centrilobular liver necrosis. By using special staining techniques, the presence of myoglobin and lipofuscin deposits was confirmed in the kidney samples. In this paper, we present a patient who developed all major complications following long-lasting arterial occlusion. We also introduce a novel method to assess the degree of ischemic injury, which may be suitable in the near future for the rapid detection of irreversible muscle injury. Therefore, the mortality of the disease might be reduced.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lower limb ischemia; Multiorgan failure; Reperfusion syndrome

Mesh:

Year:  2013        PMID: 23850181     DOI: 10.1016/j.carpath.2013.02.006

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  7 in total

1.  Biomarkers in post-reperfusion syndrome after acute lower limb ischaemia.

Authors:  Stefano de Franciscis; Giovanni De Caridi; Mafalda Massara; Francesco Spinelli; Luca Gallelli; Gianluca Buffone; Francesco G Caliò; Lucia Butrico; Raffaele Grande; Raffaele Serra
Journal:  Int Wound J       Date:  2014-12-03       Impact factor: 3.315

Review 2.  Chronology of mitochondrial and cellular events during skeletal muscle ischemia-reperfusion.

Authors:  Stéphanie Paradis; Anne-Laure Charles; Alain Meyer; Anne Lejay; James W Scholey; Nabil Chakfé; Joffrey Zoll; Bernard Geny
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-13       Impact factor: 4.249

3.  Deficiency of myostatin protects skeletal muscle cells from ischemia reperfusion injury.

Authors:  Christoph Wallner; Marius Drysch; Mustafa Becerikli; Sonja Verena Schmidt; Stephan Hahn; Johannes Maximilian Wagner; Felix Reinkemeier; Mehran Dadras; Alexander Sogorski; Maxi von Glinski; Marcus Lehnhardt; Björn Behr
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

4.  Diabetes Worsens Ischemia-Reperfusion Brain Injury in Rats Through GSK-3β.

Authors:  Hua Liu; Shanshan Ou; Xiaoyu Xiao; Yingxian Zhu; Shaopeng Zhou
Journal:  Am J Med Sci       Date:  2015-09       Impact factor: 2.378

5.  Salutary Effects of Cepharanthine against Skeletal Muscle and Kidney Injuries following Limb Ischemia/Reperfusion.

Authors:  Ming-Chang Kao; Chih-Yang Chung; Ya-Ying Chang; Chih-Kung Lin; Joen-Rong Sheu; Chun-Jen Huang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-26       Impact factor: 2.629

6.  Levosimendan Administration in Limb Ischemia: Multicomponent Signaling Serving Kidney Protection.

Authors:  Peter Onody; Peter Aranyi; Zsolt Turoczi; Rita Stangl; Andras Fulop; Emese Dudas; Gabor Lotz; Attila Szijarto
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

7.  Serum expression levels of Mb and NT-proBNP and NF-κB expression in neutrophils in patients with MODS and the clinical significance.

Authors:  Congmei Wang; Qingliang Chen; Zhenyu Cui; Zhijing Xu; Yangang Shi; Shiqiong Su; Lu Qi; Yu'an Geng; Ruifang Liu
Journal:  Exp Ther Med       Date:  2018-08-27       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.